Zhou L - Search Results

1

Novel combination of imipridones and histone deacetylase inhibitors demonstrate cytotoxic effect through integrated stress response in pediatric solid tumors.

Chang WI, Honeyman JN, Zhang J, Lin C, Sharma A, Zhou L, Oliveira J, Tapinos N, Lulla RR, Prabhu VV, El-Deiry WS. Chang WI, et al. Among authors: zhou l. Am J Cancer Res. 2023 Dec 15;13(12):6241-6255. eCollection 2023. Am J Cancer Res. 2023. PMID: 38187038 Free PMC article.

2

Multispectral fluorescence imaging.

Zhou L, El-Deiry WS. Zhou L, et al. J Nucl Med. 2009 Oct;50(10):1563-6. doi: 10.2967/jnumed.109.063925. Epub 2009 Sep 16. J Nucl Med. 2009. PMID: 19759119 Free article. Review.

3

Sorafenib inhibits ERK1/2 and MCL-1(L) phosphorylation levels resulting in caspase-independent cell death in malignant pleural mesothelioma.

Katz SI, Zhou L, Chao G, Smith CD, Ferrara T, Wang W, Dicker DT, El-Deiry WS. Katz SI, et al. Among authors: zhou l. Cancer Biol Ther. 2009 Dec;8(24):2406-16. doi: 10.4161/cbt.8.24.10824. Epub 2009 Dec 2. Cancer Biol Ther. 2009. PMID: 20038816 Free PMC article.

4

FLT-PET may not be a reliable indicator of therapeutic response in p53-null malignancy.

Katz SI, Zhou L, Ferrara TA, Wang W, Mayes PA, Smith CD, El-Deiry WS. Katz SI, et al. Among authors: zhou l. Int J Oncol. 2011 Jul;39(1):91-100. doi: 10.3892/ijo.2011.1019. Epub 2011 Apr 29. Int J Oncol. 2011. PMID: 21537838

5

Prediction of proapoptotic anticancer therapeutic response in vivo based on cell death visualization and TRAIL death ligand-receptor interaction.

Zhou L, Wang W, Dicker DT, Humphreys RC, El-Deiry WS. Zhou L, et al. Cancer Biol Ther. 2011 Aug 15;12(4):335-48. doi: 10.4161/cbt.12.4.17174. Epub 2011 Aug 15. Cancer Biol Ther. 2011. PMID: 21785270 Free article.

6

Extracellular protease imaging for cell mass tracking of xenografted human malignant pleural mesothelioma.

Zhou L, El-Deiry W, Wang W, Ingram ME, Katz SI. Zhou L, et al. Oncol Rep. 2012 Sep;28(3):883-8. doi: 10.3892/or.2012.1888. Epub 2012 Jun 26. Oncol Rep. 2012. PMID: 22751990

7

Mitomycin C potentiates TRAIL-induced apoptosis through p53-independent upregulation of death receptors: evidence for the role of c-Jun N-terminal kinase activation.

Cheng H, Hong B, Zhou L, Allen JE, Tai G, Humphreys R, Dicker DT, Liu YY, El-Deiry WS. Cheng H, et al. Among authors: zhou l. Cell Cycle. 2012 Sep 1;11(17):3312-23. doi: 10.4161/cc.21670. Epub 2012 Aug 16. Cell Cycle. 2012. PMID: 22895172 Free PMC article.

8

Acoustic separation of circulating tumor cells.

Li P, Mao Z, Peng Z, Zhou L, Chen Y, Huang PH, Truica CI, Drabick JJ, El-Deiry WS, Dao M, Suresh S, Huang TJ. Li P, et al. Among authors: zhou l. Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):4970-5. doi: 10.1073/pnas.1504484112. Epub 2015 Apr 6. Proc Natl Acad Sci U S A. 2015. PMID: 25848039 Free PMC article.

9

Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53.

Zhang S, Zhou L, Hong B, van den Heuvel AP, Prabhu VV, Warfel NA, Kline CL, Dicker DT, Kopelovich L, El-Deiry WS. Zhang S, et al. Among authors: zhou l. Cancer Res. 2015 Sep 15;75(18):3842-52. doi: 10.1158/0008-5472.CAN-13-1079. Epub 2015 Aug 20. Cancer Res. 2015. PMID: 26294215 Free PMC article.

10

Regorafenib with a fluoropyrimidine for metastatic colorectal cancer after progression on multiple 5-FU-containing combination therapies and regorafenib monotherapy.

Marks EI, Tan C, Zhang J, Zhou L, Yang Z, Scicchitano A, El-Deiry WS. Marks EI, et al. Among authors: zhou l. Cancer Biol Ther. 2015;16(12):1710-9. doi: 10.1080/15384047.2015.1113355. Cancer Biol Ther. 2015. PMID: 26561209 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33,129 results

Search Page

Filters